Methylprednisolone EP Impurity A Hydrogen Succinate
|
甲泼尼龙EP杂质A琥珀酸氢
|
|
Adenosine impurities7(Regardson impurity 8)
|
腺苷杂质7(瑞加德松杂质8)
|
|
Cefazoxime Triethylamine Impurity
|
头孢唑肟三乙胺杂质(头孢唑肟杂质22)
|
|
Relugolix Impurity 80
|
瑞卢戈利杂质80
|
|
Relugolix Impurity 82
|
瑞卢戈利杂质82
|
|
Relugolix Impurity 83
|
瑞卢戈利杂质83
|
|
Relugolix Impurity 85
|
瑞卢戈利杂质85
|
|
Gliclazide EP Impurity G
|
格列齐特EP杂质G
|
|
Fusidic Acid EP Impurity C
|
夫西地酸EP杂质C
|
|
Fusidic Acid EP Impurity E
|
夫西地酸EP杂质E
|
|
Deferiprone EP impurity C
|
去铁酮EP杂质C
|
|
Glimepiride EP impurity G
|
格列美脲EP杂质G
|
|
Cefcapene pivoxil Impurity 8
|
头孢卡品酯杂质8
|
|
Cefcapene pivoxil Impurity 5
|
头孢卡品酯杂质5
|
|
Naltrexone EP Impurity G
|
纳曲酮EP杂质G
|
|
Prilocaine hydrochloride - d7
|
盐酸丙胺卡因-d7(丙胺卡因杂质29)
|
|
Nicergoline EP Impurity E
|
尼麦角林EP杂质E
|
|
Benzylpenicillin (Benzathine)tetrahydrate EP Impurity C
|
四水合苄基青霉素(苄硫醚)EP杂质C
|
|
Benzylpenicillin (Benzathine) tetrahydrate EP Impurity K
|
四水合苄基青霉素(苄硫醚)EP杂质K
|
|
Cefprozil EP Impurity K1
|
头孢丙烯EP杂质K1(异构体)
|
|
Cefprozil EP Impurity K3
|
头孢丙烯EP杂质K3(异构体)
|
|
Cefprozil EP Impurity K4
|
头孢丙烯EP杂质K4(异构体)
|
|
Cefprozil EP Impurity L
|
头孢丙烯EP杂质L
|
|
Trimethoxycefalexin (USP)
|
甲氧基头孢羟氨苄(USP)
|
|
Cefprozil δ- Isomer at position 3 (USP
|
头孢丙烯δ-3位异构体(USP)
|
|
Cefprozil amino compound (USP)
|
头孢丙烯氨基化合物(USP)
|
|
L-Cefprozil hydrate
|
L-头孢丙烯(头孢丙烯杂质2)
|
|
D-p-hydroxyphenylglycine methyl ester
|
D-对羟基苯甘氨酸甲酯
|
|
Isavuconazole Impurity 33
|
艾沙康唑杂质33
|
|
Isoproterenol Impurity 7
|
异丙肾上腺素杂质7
|
|
Urapidil Impurity 39
|
乌拉地尔杂质39
|
|
Benserazide Impurity 4 HCI
|
苄丝肼杂质4盐酸盐
|
|
Brimonidine Dimer Impurity
|
溴莫尼定二聚体杂质
|
|
Fluticasone Furoate EP Impurity I
|
糠酸氟替卡松EP杂质I
|
|
Fluticasone Propionate EP Impurity J
|
丙酸氟替卡松EP杂质J
|
|
Dapagliflozin Impurity 27
|
达格列净杂质27
|
|
Urapidil Impurity 31
|
乌拉地尔杂质31
|
|
Urapidil Impurity 33
|
乌拉地尔杂质33
|
|
Urapidil Impurity 40
|
乌拉地尔杂质40
|
|
Epalrestat Impurity E
|
依帕司他杂质E
|
|
Cefprozil EP Impurity K2
|
头孢丙烯EP杂质K2(异构体)
|
|
L-p-hydroxyphenylglycine methyl ester
|
L-对羟基苯甘氨酸甲酯
|
127369-30-6
|
Salbutamol glyoxal
|
沙丁胺醇乙二醛
|
|
Mometasone Furoate Impurity I
|
糠酸莫米松EP杂质I
|
|
Oxacillin Impurity 7
|
苯唑西林杂质7
|
94419-27-9
|
Edoxaban Impurity 90
|
依度沙班杂质90
|
|
Ilaprazole Impurity 32
|
艾普拉唑杂质32
|
|
Mometasone Furoate Impurity P
|
糠酸莫米松EP杂质P
|
|
Mometasone Furoate Impurity T
|
糠酸莫米松EP杂质T
|
|
Cefmetazole S-Methyl Sodium salt
|
头孢美唑硫甲基钠盐(头孢美唑杂质40)
|
|
Lifitegrast Impurity 38
|
立他司特杂质38
|
|
Lifitegrast Impurity 54
|
立他司特杂质54
|
|
Lifitegrast Impurity 55
|
立他司特杂质55
|
|
heptan-2-yl carbonochloridate
|
庚烷-2-羰基氯化物
|
|
β-D-Arabinofuranose 9H-PurinoDiacetate
|
β-D-阿拉伯呋喃糖9H嘌呤二乙酸酯
|
|
Tinidazole Impurity 9
|
替硝唑杂质9
|
|
Tinidazole Denitrification Impurity
|
替硝唑去硝基杂质
|
|
Tinidazole Impurity 4
|
替硝唑杂质4
|
|
Ornithine Impurity 15
|
鸟氨酸杂质15
|
|
Ornithine Impurity 16
|
鸟氨酸杂质16
|
|
Ornithine Impurity 11
|
鸟氨酸杂质11
|
7327-72-2
|
Dapagliflozin Impurity 32
|
达格列净杂质32
|
|
Blonanserin Impurity 8
|
布南色林杂质8
|
|
Dapoxetine Impurity 61
|
达泊西汀杂质61
|
|
Dabigatran impurity 80
|
达比加群杂质80
|
1307233-94-8
|
Dabigatran impurity 81
|
达比加群杂质81
|
211915-07-0
|
Sorafenib related compound 28
|
索拉非尼相关化合物28
|
|
Sorafenib related compound 29
|
索拉非尼相关化合物29
|
|
Sorafenib related compound 30
|
索拉非尼相关化合物30
|
|
Bortezomib Impurity P
|
硼替佐米杂质P
|
|
Bortezomib Impurity 5
|
硼替佐米杂质5
|
2379402-85-2
|
Peramivir Dimer Impurity 1
|
帕拉米韦二聚体杂质1
|
|
Ticagrelor Impurity O
|
替格瑞洛杂质O
|
|
Ambroxol Impurity 27 HCl
|
氨溴索杂质27盐酸盐
|
|
Labetalol EP Impurity E
|
拉贝洛尔EP杂质E
|
|
Amoxicillin Impurity 47
|
阿莫西林杂质47
|
|
Topiramate Impurity 19
|
托吡酯杂质19
|
|
Topiramate Impurity 20
|
托吡酯杂质20
|
|
Fusidic Acid EP Impurity D
|
夫西地酸EP杂质D
|
|
Sodium 1-hydroxytanshinone Ⅱ a sulfonate
|
1- 羟基丹参酮ⅡA 磺酸钠(丹参酮ⅡA杂质1)
|
|
Sodium tanshinone Ⅱ B sulfonate
|
丹参酮ⅡB磺酸钠(丹参酮ⅡB杂质2)
|
|
Sodium Salvia miltiorrhiza mesylate
|
紫丹参甲素磺酸钠(丹参酮IIA杂质4)
|
|
Drotaverine Impurity 33
|
屈他维林杂质33
|
|
Travoprost 6
|
曲伏前列素杂质6
|
|
Travoprost 9
|
曲伏前列素杂质9
|
|
Travoprost 10
|
曲伏前列素杂质10
|
2218532-68-2
|
Travoprost 11
|
曲伏前列素杂质11
|
2218532-66-0
|
Pyridoxine Impurity 30
|
吡哆醇杂质30
|
|
Sulfasalazine IMP-K USP / EP
|
柳氮磺胺吡啶IMP-K USP / EP
|
|
Prilocaine impurity E (designated brand EP cat. No. p2939025)
|
丙胺卡因杂质E(指定品牌EP 货号P2939025)
|
|
Ofloxacin impurity D (designated brand EP cat. No. y0002202)
|
氧氟沙星杂质D(指定品牌EP 货号Y0002202)
|
|
Moxifloxacin related substance e (designated brand USP cat. No. 1448655)
|
莫西沙星相关物质E(指定品牌USP 货号1448655)
|
|
Biapenem Impurity 12
|
比阿培南杂质12
|
|
Acyclovir for system suitability / a (cat. No. y0002245)
|
阿昔洛韦用于系统适用性/A(货号Y0002245)
|
|
Acyclovir mixture / C (cat. No. y0002242)
|
阿昔洛韦混合物/C(货号Y0002242)
|
|
Cefmetazole Double Bond Isomer Impurity
|
头孢美唑双键异构体杂质(头孢美唑杂质39)
|
|
Dexrazoxane Impurity 28
|
右雷佐生(右丙亚胺)杂质28
|
|
Sodium 3-hydroxytanshinone IIA sulfonate
|
3-羟基丹参酮IIA磺酸钠(丹参酮IIA杂质3)
|
|
Bumetanide Impurity 36
|
布美他尼杂质36
|
|
Palbociclib Impurity Y
|
帕布昔利布杂质Y
|
2174002-16-3
|